Technical Support
(877) SEPAX-US, press 3      
TechSupport@sepax-tech.com

Representative Literature References

Click a row to open its literature reference.
Product PN Separation Mode
Broad Sample Type Specific Sample
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   Next   View All
Year Product PN Sep. Mode Broad Sample Category Specific Sample Title
2024Unix-C SEC-300231300-4615SECAntibodyHIV-1 Env AntibodyAbsolute quantitation of binding antibodies from clinical samples
2024Zenix-C SEC-300233300-7830SECMembrane ProteinGPCRStructural insights into CXCR4 modulation and oligomerization
2023Proteomix HIC Butyl-NP5N/AHICAntibodyMAbAntibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
2023SRT-10 SEC-300225300-21230SECProteinN/AResurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides
2023SRT SEC-1000215950-30030SECDNA/RNA/OLIGOcircRNACircular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infection
2023SRT SEC-2000215980-10030SECDNA/RNA/OLIGOcircRNAThe RNA ligation method using modified splint DNAs significantly improves the efficiency of circular RNA synthesis
2023SRT SEC-1000215950-4630SECAAVAAV9Application of Size Exclusion Chromatography with Multi-Angle Light Scattering in the Analytical Development of a Preclinical Stage Gene Therapy Program
2023Proteomix HIC Butyl-NP5431NP5-4603HICADCThienoduocarmycin-trastuzumab ADCNovel Thienoduocarmycin-trastuzumab ADC Demonstrates Strong Anti-tumor Efficacy
2023Zenix-C SEC-300233300-7830SECADCGlycan-based Site Specific ADCHiding Payload Inside the IgG Fc Cavity Significantly Enhances the Therapeutic Index of Antibody Drug Conjugates
2022Proteomix RP-1000465950-2110RPADCAnti-HER2 Immune-Stimulating ADCDesign and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   Next   View All
© 2024 Sepax Technologies, Inc. All Rights Reserved.